Overview
Matthew Zibelman is an Oncologist practicing medicine in Philadelphia, Pennsylvania.
Dr. Zibelman is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Endoscopy.
He is actively involved in clinical research, co-authoring 79 peer reviewed articles and participating in 4 clinical trials.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
333 Cottman Ave, Philadelphia, PA 19111
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Fox Chase Cancer Center
Hossein Borghaei is an Oncologist and a Radiologist practicing medicine in Philadelphia, Pennsylvania. Dr. Borghaei is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Borghaei is board certified in American Board Of Internal Medicine - Medical Oncology.
Fox Chase Cancer Center
Daniel Geynisman is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Geynisman is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy. Dr. Geynisman is board certified in American Board Of Internal Medicine - Medical Oncology.
Fox Chase Cancer Center
Elizabeth Plimack is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Plimack is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy. Dr. Plimack is board certified in American Board Of Internal Medicine - Medical Oncology.
Frequently Asked Questions about Dr. Matthew R. Zibelman
How do I make an appointment with Dr. Matthew R. Zibelman?
You can book an appointment with Dr. Matthew R. Zibelman by calling their office at 215-728-2500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Matthew R. Zibelman a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Matthew R. Zibelman is classified as an Elite expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Matthew R. Zibelman specialize in?
While Dr. Matthew R. Zibelman is a Oncology, they have specific expertise in Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, and Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Matthew R. Zibelman participate in research or clinical trials?
Yes. Dr. Matthew R. Zibelman has published 79 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Dr. Matthew R. Zibelman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Matthew R. Zibelman accept my insurance?
Dr. Matthew R. Zibelman accepts most major insurance plans, including Aetna and Avalon Health Care. We recommend calling the office directly at 215-728-2500 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Renal Cell Carcinoma (RCC)Dr. Zibelman isElite. Learn about Renal Cell Carcinoma (RCC).
- Distinguished
- Bladder CancerDr. Zibelman isDistinguished. Learn about Bladder Cancer.
- Chromophobe Renal Cell CarcinomaDr. Zibelman isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Zibelman isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Zibelman isDistinguished. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Zibelman isDistinguished. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Zibelman isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Zibelman isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- Prostate CancerDr. Zibelman isDistinguished. Learn about Prostate Cancer.
- Urothelial CancerDr. Zibelman isDistinguished. Learn about Urothelial Cancer.
- Wilms TumorDr. Zibelman isDistinguished. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Zibelman isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- Adult Soft Tissue SarcomaDr. Zibelman isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- MelanomaDr. Zibelman isAdvanced. Learn about Melanoma.
- Upper Tract Urothelial Carcinoma (UTUC)
- Experienced
- AngiosarcomaDr. Zibelman isExperienced. Learn about Angiosarcoma.
- Angiosarcoma of the ScalpDr. Zibelman isExperienced. Learn about Angiosarcoma of the Scalp.
- Breast CancerDr. Zibelman isExperienced. Learn about Breast Cancer.
- ChoriocarcinomaDr. Zibelman isExperienced. Learn about Choriocarcinoma.
- Colorectal CancerDr. Zibelman isExperienced. Learn about Colorectal Cancer.
- EndoscopyDr. Zibelman isExperienced. Learn about Endoscopy.
- Inflammatory Breast CancerDr. Zibelman isExperienced. Learn about Inflammatory Breast Cancer.
- Lung CancerDr. Zibelman isExperienced. Learn about Lung Cancer.
- MesenchymomaDr. Zibelman isExperienced. Learn about Mesenchymoma.
- Metastatic Brain TumorDr. Zibelman isExperienced. Learn about Metastatic Brain Tumor.
- Metastatic Pleural TumorDr. Zibelman isExperienced. Learn about Metastatic Pleural Tumor.
- NephrectomyDr. Zibelman isExperienced. Learn about Nephrectomy.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Zibelman isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Paget Disease of the BreastDr. Zibelman isExperienced. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Zibelman isExperienced. Learn about Pleuropulmonary Blastoma.
- Posterior Fossa TumorDr. Zibelman isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Zibelman isExperienced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Teratoma of the MediastinumDr. Zibelman isExperienced. Learn about Teratoma of the Mediastinum.
- Testicular CancerDr. Zibelman isExperienced. Learn about Testicular Cancer.
- Undifferentiated Pleomorphic SarcomaDr. Zibelman isExperienced. Learn about Undifferentiated Pleomorphic Sarcoma.